Discovering Biomarkers of Neutrophilic Asthma: A Clinician's Perspective

Overview

Journal Allergy Asthma Immunol Res

Date 2022 Jan 4

PMID 34983102

Citations 7

Authors

Noeul Kang

Woo-Jung Song

Affiliations

Soon will be listed here.

Citing Articles

TGF-β, IL-1β, IL-6 levels and TGF-β/Smad pathway reactivity regulate the link between allergic diseases, cancer risk, and metabolic dysregulations.

Elkoshi Z Front Immunol. 2024; 15:1371753.

PMID: 38629073 PMC: 11019030. DOI: 10.3389/fimmu.2024.1371753.

ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma.

Luu Quoc Q, Cao T, Jang J, Shin Y, Choi Y, Park H Allergy Asthma Immunol Res. 2024; 16(1):22-41.

PMID: 38262389 PMC: 10823144. DOI: 10.4168/aair.2024.16.1.22.

MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-κB pathway.

Liu L, Zhou L, Wang L, Mao Z, Zheng P, Zhang F Respir Res. 2023; 24(1):255.

PMID: 37880668 PMC: 10601133. DOI: 10.1186/s12931-023-02550-y.

Special Issue on 'Asthma and Allergic Inflammation'.

Pelaia C Vaccines (Basel). 2023; 11(3).

PMID: 36992115 PMC: 10057724. DOI: 10.3390/vaccines11030531.

Tiotropium Bromide Improves Neutrophilic Asthma by Recovering Histone Deacetylase 2 Activity.

An T, Kim J, Hur J, Park C, Lim J, Kim S J Korean Med Sci. 2023; 38(12):e91.

PMID: 36974400 PMC: 10042725. DOI: 10.3346/jkms.2023.38.e91.

References

Sur S, Crotty T, Kephart G, Hyma B, Colby T, Reed C . Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?. Am Rev Respir Dis. 1993; 148(3):713-9. DOI: 10.1164/ajrccm/148.3.713. View

Busse W, Holgate S, Kerwin E, Chon Y, Feng J, Lin J . Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med. 2013; 188(11):1294-302. DOI: 10.1164/rccm.201212-2318OC. View

Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L . A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med. 2007; 176(11):1062-71. DOI: 10.1164/rccm.200701-085OC. View

Hynes G, Hinks T . The role of interleukin-17 in asthma: a protective response?. ERJ Open Res. 2020; 6(2). PMC: 7248344. DOI: 10.1183/23120541.00364-2019. View

Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T . The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol. 2002; 89(4):381-5. DOI: 10.1016/S1081-1206(10)62039-X. View

Crisford H, Sapey E, Rogers G, Taylor S, Nagakumar P, Lokwani R . Neutrophils in asthma: the good, the bad and the bacteria. Thorax. 2021; . PMC: 8311087. DOI: 10.1136/thoraxjnl-2020-215986. View

Pavord I, Korn S, Howarth P, Bleecker E, Buhl R, Keene O . Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012; 380(9842):651-9. DOI: 10.1016/S0140-6736(12)60988-X. View

OByrne P, Metev H, Puu M, Richter K, Keen C, Uddin M . Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2016; 4(10):797-806. DOI: 10.1016/S2213-2600(16)30227-2. View

Thi Bich T, Luu Quoc Q, Choi Y, Yang E, Trinh H, Shin Y . Serum Amyloid A1: A Biomarker for Neutrophilic Airway Inflammation in Adult Asthmatic Patients. Allergy Asthma Immunol Res. 2022; 14(1):40-58. PMC: 8724823. DOI: 10.4168/aair.2022.14.1.40. View

10.

Moore W, Hastie A, Li X, Li H, Busse W, Jarjour N . Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol. 2013; 133(6):1557-63.e5. PMC: 4040309. DOI: 10.1016/j.jaci.2013.10.011. View

11.

Cox G . Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol. 1995; 154(9):4719-25. View

12.

Song W, Lee J, Kang Y, Joung W, Chung K . Future Risks in Patients With Severe Asthma. Allergy Asthma Immunol Res. 2019; 11(6):763-778. PMC: 6761069. DOI: 10.4168/aair.2019.11.6.763. View

13.

Kyriakopoulos C, Gogali A, Bartziokas K, Kostikas K . Identification and treatment of T2-low asthma in the era of biologics. ERJ Open Res. 2021; 7(2). PMC: 8181790. DOI: 10.1183/23120541.00309-2020. View

14.

Nair P, Surette M, Virchow J . Neutrophilic asthma: misconception or misnomer?. Lancet Respir Med. 2021; 9(5):441-443. DOI: 10.1016/S2213-2600(21)00023-0. View

15.

Bozinovski S, Uddin M, Vlahos R, Thompson M, McQualter J, Merritt A . Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A. 2012; 109(3):935-40. PMC: 3271884. DOI: 10.1073/pnas.1109382109. View

16.

Smole U, Gour N, Phelan J, Hofer G, Kohler C, Kratzer B . Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity. Nat Immunol. 2020; 21(7):756-765. PMC: 9291269. DOI: 10.1038/s41590-020-0698-1. View

17.

Wenzel S, Barnes P, Bleecker E, Bousquet J, Busse W, Dahlen S . A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med. 2009; 179(7):549-58. DOI: 10.1164/rccm.200809-1512OC. View

18.

Lee Y, Luu Quoc Q, Park H . Biomarkers for Severe Asthma: Lessons From Longitudinal Cohort Studies. Allergy Asthma Immunol Res. 2021; 13(3):375-389. PMC: 7984946. DOI: 10.4168/aair.2021.13.3.375. View

19.

Badi Y, Pavel A, Pavlidis S, Riley J, Bates S, Kermani N . Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma. J Allergy Clin Immunol. 2021; 149(1):89-101. DOI: 10.1016/j.jaci.2021.04.010. View

20.

Ozseker F, Buyukozturk S, Depboylu B, Yilmazbayhan D, Karayigit E, Gelincik A . Serum amyloid A (SAA) in induced sputum of asthmatics: a new look to an old marker. Int Immunopharmacol. 2006; 6(10):1569-76. DOI: 10.1016/j.intimp.2006.05.006. View